Fortrea
Vincent Lagrotteria MBA currently serves as the Sr Director of Business Development for Strategic Accounts at Fortrea since 2023, following a similar role at Labcorp that began in 2021. Prior experience includes Sr. Account Executive at ICON Government and Public Health Solutions, where clinical research CRO services were sold, and Sr. Manager of Business Development at Emergent BioSolutions, focusing on drug substance manufacturing. Vincent has also held significant leadership roles at PPD, Bridge Laboratories, Medifacts International, and IQVIA. In addition to extensive business development experience, Vincent served as an Affiliate Professor at Loyola University Maryland Sellinger School of Business and Management, teaching and mentoring students in Marketing, Sales, and Leadership. Educational credentials include an MBA in Marketing from Loyola University Maryland and a BS from Towson University.
This person is not in any teams
This person is not in any offices
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.